| ¿µ¹® | carcinoma in situ | ÇÑ±Û | »óÇdz»¾ÏÁ¾ |
|---|---|---|---|
| ¼³¸í | ½ÅüÀÇ ³»ºÎ³ª ¿ÜºÎ¸¦ ½×°í ÀÖ´Â Á¶Á÷À» »óÇǶó°í ÇÑ´Ù. ÀÌ »óÇÇÀÇ ¾Æ·¡¿¡´Â ´ë°³ »óÇǸ¦ ÁöÁöÇϰí ÀÖ´Â Á¶Á÷ÀÇ À§¿¡ Á¸ÀçÇÑ´Ù. ±×¸®°í ÀÌ ÁöÁöÁ¶Á÷°ú »óÇÇ »çÀÌ¿¡´Â ±âÀú¸·À̶ó´Â ¸·ÀÌ ÀÖ¾î¼ »óÇÇ¿Í ÁöÁöÁ¶Á÷À» ±¸ºÐÇØ ÁØ´Ù. ¾ÏÁ¾(carcinoma)¶õ »óÇÇÀÇ ¼¼Æ÷°¡ ¾Ç¼º º¯È¸¦ ÇÏ¿© »ý±â´Â ¾ÏÀ» ¸»ÇÑ´Ù. Á¦ÀÚ¸®¾ÏÁ¾À̶õ ¾ÏÁ¾ÀÇ ÇÑ Á¾·ù·Î ¾ÏÁ¾ÀÌ ±âÀú¸·À» ¹þ¾î³ªÁö ¸øÇÏ°í »óÇdz» Áï, Á¦ÀÚ¸®¿¡ ¸Ó¹°·¯ ÀÖ´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. |
||
| ¿µ¹® | funnel breast | ÇÑ±Û | ¿À¸ñ°¡½¿, ´©µÎÈä |
|---|---|---|---|
| ¼³¸í | ¾Õ°¡½¿ÀÇ Á߾Ӻΰ¡ ±ò´ë±â ¸ð¾çÀ¸·Î ÇÔ¸ôµÇ¾î ÀÖ´Â °Í. ´ëºÎºÐ À¯Àü¼ºÀ¸·Î ½ÉÇÑ °æ¿ì¿¡´Â ½ÉÀåÀ̳ª ÇãÆÄ¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. Àα¸ 300~400¸íÀÇ ½Å»ý¾Æ Áß 1¸íÀÌ ÀÌ Áúȯ¿¡ °É¸± ¼ö ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. º¸Åë ÀÌ Áõ»óÀ» °®°í ÀÖ´Â »ç¶÷Àº ¸¶¸¥Ã¼ÇüÀ̰í ôÃßÈĸ¸ µî ÀÚ¼¼ÀÇ ÀÌ»óÀ» µ¿¹ÝÇÏ´Â °æ¿ì°¡ ¸¹´Ù. º¸Åë ½Å»ý¾Æ±â, ¿µ¾Æ±â µî ¾î·Á¼ºÎÅÍ ¾Ë°Ô µÇ¸ç, ±âÇüÀûÀÎ ¸ð½À ¶§¹®¿¡ Çб³»ýȰÀ̳ª »çȸ»ýȰÀ» ÇÒ ¶§ ÁöÀåÀ» ¹ÞÀ» ¼öµµ ÀÖ´Ù. ³²ÀÚ¿¡°Ô ¸¹ÀÌ ¹ß»ýÇϰí, »ó±âµµÆó»ö-±â°üÁö¿¬ÈÁõ°ú °ü·ÃµÇ¾î »ý±æ ¼öµµ ÀÖ´Ù. º¸ÅëÀÇ °æ¿ì Áõ»óÀÌ ¾øÁö¸¸, ½ÉÇÑ °æ¿ì ½ÉÆó±â´ÉÀÇ Àå¾Ö·Î ÀÎÇØ ¿îµ¿ÇÒ ¶§ ¼ûÀÌ Â÷°í, ¹Ýº¹µÇ´Â °¨±âÁõ»óÀÌ ÀÖÀ» ¼ö ÀÖ´Ù. ½Â¸ðÆÇ Å»Ãâ, Á¶±âÈïºÐÁõÈıºÀÌ ³ªÅ¸³ª´Â °æ¿ìµµ ÀÖ´Ù. |
||
| ¿µ¹® | fibrocystic disease of breast | ÇÑ±Û | À¯¹æ ¼¶À¯³¶º´ |
|---|---|---|---|
| ¼³¸í | Á¥À» »ý»êÇÏ´Â Á¥»ù³»¿¡ ¿ÏµÎÄá ¶Ç´Â Å«Äá Å©±âÀÇ °áÀýÀÌ ¹ß»ýÇÏ´Â Áõ¼¼¸¦ Ư¡À¸·Î ÇÏ´Â º´. 30~50´ëÀÇ ºÎÀο¡°Ô ÈçÈ÷ ¹ß»ýÇϸç, ±× ´ëºÎºÐÀº ¾çÂÊ À¯¹æ¿¡ µ¿½Ã¿¡ ¹ß»ýÇÑ´Ù. ÀÌ·¯ÇÑ °áÀýÀº µÎ ¼Õ°¡¶ô »çÀÌ¿¡ ³¢¿ö ÃËÁøÇÒ ¶§´Â ºÐ¸íÇÏÁö¸¸, È亮À» ¼Õ¹Ù´ÚÀ¸·Î ´©¸£¸é ¸í·áÇÏÁö ¾ÊÀ» Á¤µµ·Î ºÎµå·¯¿î °ÍÀÌ ¸¹´Ù. ±× ¹ß»ý ¿øÀο¡´Â ¿©·¯ °¡Áö ¼³ÀÌ ¸¹Àºµ¥, Á¥»ùÁ¶Á÷¿¡ ´ëÇÑ ¸¸¼ºÀûÀÎ ÀÚ±ØÀÌ ÁÖ¿øÀÎÀ̶ó »ý°¢µÇ°í ÀÖÀ¸¸ç, ±ØÈ÷ ¼¼È÷ ÁøÇàÇÏ´Â °æ°ú¸¦ ¹â´Â´Ù. Áø´ÜÀº ÃËÁø, ÃÊÀ½ÆÄÁø´Ü µîÀ¸·Î Çϸç, ¾Ï°ú °¨º°ÀÌ °ï¶õÇÒ ¶§´Â Á¶Á÷ÀÇ ÀϺθ¦ äÃëÇÏ¿© °Ë»çÇÏ´Â »ý°ËÀÌ ÀÌ¿ëµÇ±âµµ ÇÑ´Ù. |
||
| ¿µ¹® | breast cancer | ÇÑ±Û | À¯¹æ¾Ï |
|---|---|---|---|
| ¼³¸í | À¯¹æÀº Áö¹æÁ¶Á÷°ú º»·¡ÀÇ ¸ñÀûÀÎ Á£À» »ý»êÇÏ´Â »ùÁ¶Á÷, ±×¸®°í ÀÌ »ùÁ¶Á÷¿¡¼ »ý»êÇÑ Á£À» ¹Û¿¡±îÁö ³»º¸³»´Â °üÁ¶Á÷, ±×¸®°í ÀÌ »ùÁ¶Á÷°ú °üÁ¶Á÷ÀÇ ÁÖÀ§¸¦ µÑ·¯½Î°í ÀÖÀ¸¸é¼ À̰͵éÀÇ ¸ð¾çÀ» À¯ÁöÇØÁÖ´Â °£Áú·Î ÀÌ·ç¾îÁø´Ù. À¯¹æ¾ÏÀ̶õ »ùÁ¶Á÷°ú °üÁ¶Á÷¿¡¼ ±â¿øÇÏ´Â Á¾¾çÀ» ¸»ÇÑ´Ù. À¯¹æ¾ÏÀ» ¹ß»ý½Ãų ¼ö ÀÖ´Â À§ÇèÀÎÀÚ´Â ¿©·¯ °¡Áö°¡ ¹àÇôÁ® ÀÖ´Ù. ±×Áß¿¡¼ ´ëÇ¥ÀûÀÎ °ÍÀº ´ÙÀ½°ú °°´Ù. 1.À¯ÀüÀû ¿äÀΣ°¡Á· Áß¿¡¼ À¯¹æ¾Ï¿¡ °É¸° »ç¶÷ÀÌ ÀÖÀ¸¸é À¯¹æ¾ÏÀÇ ¹ß»ýÈ®·üÀÌ ¾ÆÁÖ ³ô¾ÆÁø´Ù. 2.¿¡½ºÆ®·Î°Õ¿¡ Àå±âÀûÀ¸·Î ¸¹ÀÌ Æø·ÎµÇ´Â °æ¿ì£¿¡½ºÆ®·Î°ÕÀº ¿©¼ºÈ£¸£¸óÀ¸·Î ¿©¼º¿¡¼ Á¤»óÀûÀ¸·Î »ý¸®ÀÇ Áֱ⿡ µû¶ó Áõ°¨À» µÇÇ®ÀÌÇÑ´Ù. ÀÌ ¿¡½ºÆ®·Î°ÕÀº À¯¹æÀÇ Á¥»ùÁ¶Á÷°ú °üÁ¶Á÷ÀÇ Áõ½Ä°ú ¼ºÀå¿¡ °ü°èÇÑ´Ù. ±×¸®°í ÀÌ ¿¡½ºÆ®·Î°Õ¿¡ ¸¹ÀÌ Æø·ÎµÇ´Â »ç¶÷Àº À¯¹æ¾ÏÀÇ È®·üÀÌ ³ô´Ù. ¿ÜºÎ¿¡¼ ¿¡½ºÆ®·Î°ÕÀÇ Á¦Á¦¸¦ Ä¡·á¸ñÀûÀ¸·Î Åõ¿©ÇÒ °æ¿ì¿¡ À¯¹æ¾ÏÀÇ ¹ß»ýÈ®·üÀº Á¤»óÀο¡¼ º¸´Ù ÇöÀúÇÏ°Ô ³ô¾ÆÁø´Ù. ±×¸®°í ¾ÆÀ̸¦ ³ºÁö ¾Ê°í Æò»ýÀ» »ç´Â ¿©ÀÚÀÇ °æ¿ì¿¡ ÀÓ½ÅÀ» ÇÏ°í ¾ÆÀ̸¦ ³ºÀº ¿©ÀÚ¿¡ ºñÇØ¼ ¿¡½ºÆ®·Î°Õ¿¡ ¸¹ÀÌ Æø·Î°¡ µÇ¹Ç·Î(ÀӽŽÿ¡´Â ºñÀӽŽú¸´Ù ¿¡½ºÆ®·Î°Õ¿¡ Àû°Ô Æø·Î°¡ µÈ´Ù)À¯¹æ¾ÏÀÇ È®·üÀÌ ³ô´Ù. 3.ȯ°æÀû ¿äÀΣÁö¹æÁú ¼·ÃëÀÇ Áõ°¡, ¼úÀÇ ¼·Ãë µîÀº À¯¹æ¾ÏÀÇ È®·üÀ» ³ôÀδÙ. À¯¹æ¾ÏÀÇ Áõ»óÀ¸·Î °¡Àå ¸¹Àº °ÍÀº ¾ÆÇÁÁö ¾ÊÀº À¯¹æÀÇ µ¢¾î¸®ÀÌ´Ù. ±×¸®°í À¯µÎ¿¡¼ ºÐºñ¹°ÀÌ ³ª¿À°Å³ª, À¯¹æÀÇ ÇǺκ¯È µîÀÌ À¯¹æ¾ÏÀÇ ÈçÇÑ Áõ»óÀÌ´Ù. Ä¡·á´Â À¯¹æÀÇ ÀýÁ¦¼úÀÌ °¡Àå È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·Î µÇ¾îÀÖ´Ù. ±×¸®°í À̰Ϳ¡ ´õÇÏ¿© ¹æ»ç¼± Ä¡·á³ª Ç×¾ÏÁ¦¿ä¹ýµµ È¿°ú°¡ ÀÖ´Â °ÍÀ¸·Î µÇ¾îÀÖ´Ù. ¶Ç ¿¡½ºÆ®·Î°ÕÀÇ °úÀ×°ú °ü°è°¡ ÀÖ´Â Á¾¾çÀÏ °æ¿ì¿¡´Â ¿¡½ºÆ®·Î°ÕÀÇ È¿°ú¸¦ Â÷´ÜÇÏ´Â ¾à¹°µµ È¿°ú°¡ ÀÖ´Ù. |
||
| ¿µ¹® | thyroid carcinoma | ÇÑ±Û | °©»ó»ù¾ÏÁ¾ |
|---|---|---|---|
| ¼³¸í | °©»ó»ù¿¡ »ý±ä »óÇǼ¼Æ÷·Î ÀÌ·ç¾îÁø ¾Ç¼ºÁ¾¾ç¹°. º´¸®Á¶Á÷ÇÐÀûÀÎ ÇüÅ¿¡ µû¶ó À¯µÎ»ó, ¼ÒÆ÷»ó, ¿ªÇü¾ÏÁ¾ ¹× ¼öÁú¾ÏÁ¾, ¸²ÇÁÁ¾ µîÀ¸·Î ³ª´ ¼ö ÀÖ´Ù. ´Ù¾çÇÑ ¿øÀÎÀÌ ÀÖÀ¸³ª, ÀϺο¡¼´Â ¹æ»ç¼±Æø·Î¿¡ ÀÇÇØ ¹ß»ýÇÑ´Ù. Ä¡·á´Â ¼ö¼ú, ¹æ»ç¼º ¿Á¼Ò, T4 ¾ïÁ¦¿ä¹ý µîÀÌ »ç¿ëµÈ´Ù. |
||
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
|---|---|
| STANDOUT | soft thresholding and depth cueing of unspecified techniques |
| URD | unspecified respiratory disease; upper respiratory disease |
| CIS | Carcinoma In Situ |
| CIN | 3, CIN III cervical intraepithelial neoplasia, grade 3 (severe dysplasia and carcinoma in situ) |
| AIS | Adeno-carcinoma in situ |
|---|---|
| CIS | Carcinoma in Situ |
| DCIS | Duct carcinoma in situ |
| DCIS | Ductal Carcinoma In Situ |
| LCIS | Lobular carcinoma in situ |
| carcinoma in situ | Cancer that involves only the cells in which it began and has not spread to other tissues. Lobular carcinoma in situ is found in the lobules of the breast. Ductal carcinoma in situ (also called intraductal carcinoma) arises in the ducts. (16 Dec 1997) |
|---|---|
| ductal carcinoma in situ | <oncology, tumour> A cancer inside the ducts of breast that has not grown through the wall of the duct into the surrounding tissues. Sometimes referred to as a precancer. Good prognosis is involved with in situ cancers. (09 Oct 1997) |
| lobular carcinoma in situ | <tumour> Carcinoma of the breast in which small tumour cells fill preexisting acini within lobules, without invading the surrounding stroma. Synonym: lobular carcinoma in situ, lobular neoplasia. (05 Mar 2000) |
| breast carcinoma | <oncology> The uncontrolled growth of malignant breast tissue. Breast cancer is currently the most common cancer in women and the leading cause of cancer-related death in the 15-54 age group. Strong risk factors include a prior history for breast cancer or a positive family history for breast cancer. Early detection is possible through the use of monthly breast self-examination, annual clinical exams and mammography. WWW: cancerNET document for patients WWW: cancerNET document for clinicians (05 Jan 1998) |
| adenocarcinoma in situ | A noninvasive abnormal proliferation of glands believed to precede the appearance of invasive adenocarcinoma; reported in the endometrium, large intestine, cervix, and other sites. (05 Mar 2000) |
| malignant melanoma in situ | A melanoma limited to the epidermis and composed of nests of atypical melanocytes and scattered single cells extending into the upper epidermis; local excision is curative although the lesion, if untreated, may soon invade the dermis. Malignant lentigo may be considered a slowly progressive type of malignant melanoma in situ. (05 Mar 2000) |
| in situ | In the natural or normal place, confined to the site of origin without invasion of neighbouring tissues. (18 Nov 1997) |
| in situ hybridisation | <molecular biology, technique> Use of a DNA or RNA probe todetect the presence of the complementaryDNA sequence in cloned bacterial or cultured eukaryotic cells.Also used for locating geneson chromosomes. The process is: Prepare microscope slide with cells in metaphase of mitosis, Treat slide with a weak base. Thus denaturing the DNA. Pour radioactively labelled probe onto the slide. Expose slide to photographic emulsion for a few days or weeks. Develop emulsion. (13 Oct 1997) |
| in situ hybridization | <molecular biology> The use of a DNA or RNA probe to detect the complementary DNA sequence. (12 Dec 1998) |
| in situ nucleic acid hybridization | <molecular biology> The use of a DNA or RNA probe to detect the complementary DNA sequence. (12 Dec 1998) |
| fluorescence in situ hybridization | <molecular biology, technique> A type of in situ hybridization in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. Acronym: FISH (25 Jun 1999) |
| fluorescent in situ hybridization | See FISH. (12 Dec 1998) |
| accessory breast | A milk-secreting gland located elsewhere than at the normal place on the chest and existing in addition to the two usual mammae. Synonym: mamma accessoria, accessory breast, supernumerary mamma. (05 Mar 2000) |
| bed of breast | Structures against which the posterior surface of the breast lies; includes mainly the pectoralis major muscle, but also some serratus anterior and external abdominal oblique muscle; extends from second to sixth rib, and from parasternal to anterior axillary lines. (05 Mar 2000) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|